CEO Edgar Montero said the license would allow the company to service the 15 million people in the Northern California market
(), which is now a subsidiary of Inc () (OTCMKTS:CADMF), said Monday that it has won state-wide manufacturing and distribution licenses for its facility in Point Arena, California.
In July, the company’s subsidiary scored a provisional distribution license from the California Bureau of Cannabis Control for adult-use and medicinal cannabis products.
In its statement, the company said GSRX Industries has received state-wide manufacturing and distribution licenses for its Facility in Point Arena, California. The facility in Northern California will allow Chemesis to supply dispensaries with high-quality finished goods.
READ: GSRX Industries, now a unit of Chemesis, posts most quarterly revenue to date
The company's Point Arena facility will boost its foothold in the northern California market and will focus on THC manufacturing and distribution. The Company will distribute finished goods to dispensaries including Chemesis’ Green Room dispensary, which is located in Point Arena.
The Point Arena facility is currently under construction and is expected to be completely built with final occupancy permits granted by the fourth quarter. The company’s extraction services will remain at its state-of-the-art Cathedral City facilities.
“The Northern California market is home to over 15 million people,” said Chemesis International CEO Edgar Montero.
“The company believes this market is currently underserviced and lacks high-quality manufacturing and products. The facility will allow Chemesis to establish operations and begin to build distribution, manufacturing and retail relationships with operating dispensaries in the Northern California market,” he added.
Contact Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
